Klk Capital Management LLC Tg Therapeutics, Inc. Transaction History

Klk Capital Management LLC

  • $75.7 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$15.2 - $35.51 $695,582 - $1.63 Million
-45,762 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$21.78 - $40.45 $345,387 - $641,456
15,858 Added 53.03%
45,762 $1.52 Million
Q2 2021

Aug 13, 2021
BUY
$32.5 - $48.96 $971,880 - $1.46 Million
29,904 New
29,904 $1.16 Million

Others Institutions Holding TGTX

# of Institutions
269
Shares Held
87.7M
Call Options Held
2.72M
Put Options Held
1.74M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $2.76B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Klk Capital Management LLC Portfolio

Follow Klk Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klk Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klk Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email